BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 2 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 2 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 4 days ago
ADVERTISEMENT
Market News

Fitbit is betting on Versa for a revival

Fitbit’s (FIT) foray into the competitive smartwatch space a few years ago was an effort to turn the table with respect to the declining market share and share price. However, despite impressing Wall Street analysts, the Fitbit Ionic failed to compete with the likes of Apple (AAPL) watch in the market. In a last-ditch attempt, […]

April 26, 2018 2 min read

Fitbit’s (FIT) foray into the competitive smartwatch space a few years ago was an effort to turn the table with respect to the declining market share and share price. However, despite impressing Wall Street analysts, the Fitbit Ionic failed to compete with the likes of Apple (AAPL) watch in the market.

In a last-ditch attempt, the California-based company this month released a successor to Ionic brand, called ‘Versa,’ which is compatible with both Android and iOS devices. Versa, which is priced at $200, is $50 cheaper than Apple Series 1 and is said to be more comfortable than its predecessor.

Courtesy- Wikimedia Commons

Despite the low price, Versa boasts of a battery life of up to 4 hours and numerous other features including sleep tracking, distance tracking, heart rate monitoring and calorie count. Unlike Ionic, Versa has done away with a dedicated GPS and instead, depends on phone’s GPS. Versa’s USP is probably its newest feature that tracks female health, including ovulation and periods.

This feature will be made available to users next month onwards. Despite the successful launch of Ionic, CEO James Park had admitted that the product had failed to meet the aggressive financial goals set by the company.

Though Ionic carried many features currently present in Versa, it failed to appeal to the consumers. Fitbit is hoping to correct that part with this new launch. Separately, Fitbit is also making an effort to enter in the fast-growing healthcare space by acquiring a health startup Twine Health earlier this year

ADVERTISEMENT
ADVERTISEMENT